Watch: Frontier IP CEO Neil Crabb discusses how the innovation hub will help to accelerate growth
Frontier IP’s innovation hub, to be developed in partnership with Abstract Securities, will help to support portfolio and other start-up and early stage companies. Neil explains more in this video.
Read moreFrontier IP to open innovation hub in Cambridge
Frontier IP has entered into a strategic partnership with Abstract Mid-Tech Limited (“Abstract”), an associate company of Abstract Securities Limited, a specialist in commercial property development, investment and venture capital financing, to create a new innovation hub in Cambridge.
Read moreWatch: Alusid CEO on the company’s European expansion
Alasdair Bremner discusses Alusid’s distribution deal with 3D Wall Panels Italia. It is the Company’s second international agreement, following the deal with Dutch sustainable materials specialist FRONT Materials. It is a further milestone achieved as Alusid explores options for an IPO.
Read moreAlusid expands in Europe with Italian distribution agreement
Alusid has signed a distribution agreement with 3D Wall Panels Italia, a leading supplier based in Milan whose clients include Primark, Zara, Lavazza and Club Med. It follows the deal with Dutch distributor FRONT Materials BV signed earlier this year.
Read moreThe Vaccine Group’s African Swine Fever vaccine enters animal trials
African Swine Fever is a highly contagious and devasting disease prevalent worldwide. There is currently no safe and effective vaccine. A vaccine candidate developed The Vaccine Group in collaboration with The Pirbright Institute has now entered animal trials.
Read moreWatch: TVG CEO Jeremy Salt on Syva collaboration and what’s next for the company
The Vaccine Group has entered a collaboration with global animal health group Syva to develop a vaccine against zoonotic pig disease Streptococcus suis. CEO Jeremy Salt discusses the partnership, other vaccine developments and the company’s work on biotherapeutics.
Read moreAnimal health group Syva to collaborate with The Vaccine Group
The Vaccine Group has entered into a collaboration with leading Spanish animal health group Syva to develop a vaccine against Streptococcus suis, an economically damaging and zoonotic pig disease.
Read moreWatch: DeakinBio CEO Aled Roberts’ TEDx talk on lessons from Martian materials engineering
From stone, to copper, then bronze, iron, steel, concrete, plastics and now silicon, human technological progress has always been underpinned by advancements in materials science. In this talk, Aled explains how investigating the enormous challenges associated with colonising the Moon and Mars led him on an accidental journey to discover how innovations in material science could have a huge impact here on Earth.
Read moreWatch: Neil Crabb on half year results, funding rounds and other highlights
Frontier IP Chief Executive Officer Neil Crabb on the Group’s first half results, the strong backing from big name investors in the Group’s portfolio companies and developments across the portfolio in this interview with Proactive’s Stephen Gunnion.
Read moreWatch: 2D Photonics CEO Ben Jensen discusses €25 million fundraising, scale up plans and future applications
2D Photonics CEO Ben Jensen talks about the company’s recent €25 million funding round and its plans to scale up its advanced graphene-based photonics technology. He discusses the growing demand for faster, more cost-effective data transmission solutions, driven by sectors such as AI and 5G.
Read more